AlphAIalphai — Financial news for AI agents
SEC EDGARJUN 222 min read$CGC

Stewart Thomas Carlton sold $9K of CGC

Stewart Thomas Carlton (See Remarks) sold 9,285 shares of Canopy Growth Corp (CGC) at $0.97 on 2026-06-17.

Original reporting
SEC EDGAR · Stewart Thomas Carlton
Published Jun 22, 2026, 8:32 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 22, 2026, 8:34 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$CGC
Neutral
medium confidence
Mentioned
$CGC
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CGCNeutralLow
01

Why it matters

The newest fact is the reported open-market sale details (shares, price, total value, post-transaction holdings).

02

Market read

Traders may note insider selling, but there is no accompanying fundamental update (earnings, guidance, deal, or regulatory action).

03

What to watch

The filing lacks context on total holdings, tax obligations, or whether other insiders are buying; traders should avoid over-weighting a single small sale.

Relevance 3/10Novelty 3/10Timing: after-hours/filing update on 2026-06-22 for a 2026-06-17 sale

Background

The article is an SEC Form 4 insider transaction disclosure for Canopy Growth (CGC).

Company-level read

Ticker impact

$CGCNeutralMedium confidence
Context

Form 4 shows officer Stewart Thomas Carlton sold 9,285 shares of Canopy Growth at $0.9741 on 2026-06-17.

Expected impact

Likely limited near-term impact; any effect would be sentiment-only unless paired with other disclosures.

Evidence & confidence

The filing is a disclosed sale (not a buy), but it is small relative to typical float and provides no new operational/regulatory/financial catalyst.

Market effects

Sector

Minimal; this is company-specific insider transaction disclosure with no sector-wide catalyst.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Insider sales under a non-10b5-1 plan can still be driven by diversification/taxes; without follow-on buys or guidance changes, the signal may be noise.

Key entities

  • issuer
    Canopy Growth Corp

    Subject of the Form 4 insider transaction disclosure.

  • insider
    Stewart Thomas Carlton

    Officer who sold 9,285 shares of CGC.

Read at source← All news

Related articles

AUG 7
$CGCMed

Canopy Growth Q1 Earnings Call Highlights

Canopy Growth (NASDAQ:CGC) reported Q1 Canadian adult-use revenue up 10% to C$29.7 million and international revenue up 10% year over year, citing growth in Poland. Adjusted consolidated gross margin rose to 31% from 25% a year earlier. Storz & Bickel revenue rose 6% to C$16.1 million. Canopy said it expects UK flower shipments to start imminently, with revenue in 2H FY2027.

yahoo.com6 min
AUG 7
$CGCMedAI 8/10

Canopy Growth Reports First Quarter Fiscal Year 2027 Financial Results; Delivers 13% Net Revenue Growth with Contributions from All Businesses

Canopy Growth (TSX: WEED, Nasdaq: CGC) reported Q1 FY2027 results for the three months ended June 30, 2026. Consolidated net revenue rose 13% to C$81.2M, with growth across Canada medical, Canada adult-use, and international. Adjusted gross margin increased to 31% and the adjusted EBITDA loss narrowed 59% to C$3.2M. Free cash outflow widened to C$25.7M.

montrealgazette.com6 min
AUG 7
$CGCMed

Canopy Growth Corp (CGC): Results of Operations and Financial Condition

Canopy Growth Corp (CGC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 cgc-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Canopy Growth Reports First Quarter Fiscal Year 2027 Financial Results; Delivers 13% Net Revenue Growth with Contributions from All Businesses Net revenue growth of 22% in Canada medical cannabis, 10% in Canada adult-use canna

SEC EDGAR 8-K6 min
JUN 15
$CGCMed

Cannabis Catalysts: Canopy Growth's FY2026 Revenue Climbs as High Tide Adds Four Ontario Stores

Canopy Growth reported Q4 FY2026 net revenue of C$71.2 million (+10% YoY) and full-year revenue of C$284.6 million (+6%). Canada medical revenue rose 27% to C$25.3 million and international revenue rose 68% to C$8.6 million. Canopy ended FY2026 with C$131.3 million net cash and expects positive Adjusted EBITDA in FY2027. High Tide agreed to buy four Ontario stores for C$7.74 million, adding to 228 Canna Cabana locations in Canada and 103 in Ontario, pending TSXV and AGCO approvals.

investorideas.com6 min
JUN 15
$CGCMed

Canopy Growth Corp (CGC): Results of Operations and Financial Condition

Canopy Growth Corp (CGC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 cgc-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Canopy Growth Reports Fourth Quarter and Fiscal Year 2026 Financial Results; Delivers Q4 FY2026 Net Revenue Growth of 27% in Canada Medical and 68% in International Markets Cannabis Full-year 2026 growth driven by net revenue

SEC EDGAR 8-K6 min